You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

eculizumab

Showing 26 - 50 of 65
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myasthenia Gravis Trial in Canada, United Kingdom, United States (eculizumab, Placebo)

Terminated
Has Results
  • Myasthenia Gravis
  • eculizumab
  • Placebo
  • Birmingham, Alabama
  • +24 more
Sep 13, 2019

Stage V Chronic Kidney Disease Trial in Worldwide (Eculizumab)

Completed
Has Results
  • Stage V Chronic Kidney Disease
  • Eculizumab
  • Adelaide, Australia
  • +14 more
Jan 30, 2019

Dense Deposit Disease, Membranoproliferative Glomerulonephritis Trial in New York (Eculizumab)

Completed
Has Results
  • Dense Deposit Disease
  • Membranoproliferative Glomerulonephritis
  • Eculizumab
  • New York, New York
  • +1 more
Feb 17, 2019

Thrombocytopenia, Alloimmune Platelet Refractoriness Trial run by the NHLBI (Eculizumab)

Completed
Has Results
  • Thrombocytopenia
  • Alloimmune Platelet Refractoriness
  • Eculizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 12, 2018

Hemoglobinuria, Paroxysmal Trial in Orange, Pensacola, Memphis (Eculizumab)

Completed
Has Results
  • Hemoglobinuria, Paroxysmal
  • Eculizumab
  • Orange, California
  • +2 more
Oct 3, 2018

Diabetes Trial in Uppsala (Eculizumab)

Completed
  • Diabetes Mellitus
  • Eculizumab
  • Uppsala, Sweden
    Dept of Surgical Sciences, Section of Transplantation Surgery, U
Oct 3, 2018

End-Stage Renal Disease, Kidney Failure, Graft Reperfusion Injury Trial in Moscow (eculizumab)

Completed
  • End-Stage Renal Disease
  • +2 more
  • eculizumab
  • Moscow, Russian Federation
    Russian Scientfic Center of Surgery
Aug 28, 2018

Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (Eculizumab, Placebo)

Terminated
Has Results
  • Neuromyelitis Optica
  • Neuromyelitis Optica Spectrum Disorder
  • Eculizumab
  • Placebo
  • Scottsdale, Arizona
  • +69 more
Jun 7, 2019

Kidney Transplant Trial in Rochester (Eculizumab)

Completed
Has Results
  • Kidney Transplant
  • Eculizumab
  • Rochester, Minnesota
    Mayo Clinic
May 23, 2018

Refractory Generalized Myasthenia Gravis Trial in Worldwide (Eculizumab, Placebo)

Completed
Has Results
  • Refractory Generalized Myasthenia Gravis
  • Eculizumab
  • Placebo
  • Birmingham, Alabama
  • +113 more
Jul 12, 2019

Delayed Graft Function Trial in Worldwide (Eculizumab, Placebo)

Completed
Has Results
  • Delayed Graft Function
  • Eculizumab
  • Placebo
  • Birmingham, Alabama
  • +77 more
Dec 3, 2018

Delayed Graft Function, Kidney Transplantation, Complement Activity Trial in United States (Eculizumab, Normal Saline)

Terminated
  • Delayed Graft Function
  • +2 more
  • Eculizumab
  • Normal Saline
  • New Haven, Connecticut
  • +4 more
Feb 23, 2018

Kidney Transplant Trial in Rochester (Eculizumab)

Terminated
Has Results
  • Kidney Transplant
  • Eculizumab
  • Rochester, Minnesota
    Mayo Clinic
Jan 8, 2018

Membranoproliferative Glomerulonephritis Trial in Italy (Eculizumab)

Completed
  • Membranoproliferative Glomerulonephritis
  • Eculizumab
  • Bari, BA, Italy
  • +12 more
Jan 15, 2018

Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants

Completed
  • Thrombotic Microangiopathy
  • Disorder Related to Bone Marrow Transplantation
  • eculizumab
  • New York, New York
    New York Presbyterian Hospital
Mar 28, 2018

Antibody-mediated Rejection, Humoral Rejection Trial in San Francisco, Boston, Ann Arbor (drug, biological, procedure)

Terminated
Has Results
  • Antibody-mediated Rejection
  • Humoral Rejection
  • Eculizumab
  • +2 more
  • San Francisco, California
  • +2 more
Aug 24, 2017

Gullain Barre Syndrome Trial in Japan (Eculizumab, Placebo)

Completed
  • Gullain Barre Syndrome
  • Eculizumab
  • Placebo
  • Nagoya, Aichi, Japan
  • +12 more
Oct 10, 2017

Paroxysmal Hemoglobinuria, Nocturnal Trial in Worldwide (eculizumab)

Completed
Has Results
  • Paroxysmal Hemoglobinuria, Nocturnal
  • eculizumab
  • Stanford, California
  • +39 more
Feb 11, 2018

Cold Agglutinin Disease Trial in Essen (Eculizumab)

Completed
  • Cold Agglutinin Disease
  • Eculizumab
  • Essen, Germany
    Department of Hematology, University Hospital Essen
Jul 17, 2017

Paroxysmal Hemoglobinuria, Nocturnal Trial run by the NHLBI (Eculizumab)

Completed
  • Paroxysmal Hemoglobinuria, Nocturnal
  • Eculizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Antibody Mediated Rejection Trial in Worldwide (Eculizumab)

Terminated
Has Results
  • Antibody Mediated Rejection
  • Eculizumab
  • Birmingham, Alabama
  • +40 more
Sep 4, 2017

Age-Related Macular Degeneration Trial in Miami (Eculizumab, Saline)

Completed
Has Results
  • Age-Related Macular Degeneration
  • Miami, Florida
    Bascom Palmer Eye Institute
Apr 29, 2017

Atypical Hemolytic-Uremic Syndrome Trial in Worldwide (Eculizumab)

Completed
Has Results
  • Atypical Hemolytic-Uremic Syndrome
  • Eculizumab
  • Burlington, Massachusetts
  • +22 more
Apr 20, 2017

Atypical Hemolytic Uremic Syndrome (aHUS) Trial in Nagano, Tokyo (Eculizumab)

Completed
  • Atypical Hemolytic Uremic Syndrome (aHUS)
  • Eculizumab
  • Nagano, Japan
  • +1 more
Mar 9, 2017

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Trial in Chapel Hill (Standard of care treatment, eculizumab)

Withdrawn
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
  • Standard of care treatment
  • eculizumab
  • Chapel Hill, North Carolina
    UNC Kidney Center
Feb 17, 2017